Tolerance of epicardial coronary endothelium and smooth muscle to hyperkalemia

G W He1, C Q Yang, G J Wilson

  • 1Hospital for Sick Children, Toronto, Ontario, Canada.

Insights

High potassium concentrations in cardioplegia did not impair endothelial function in porcine coronary arteries. This study found no significant detrimental effects of hyperkalemia on endothelium-derived relaxing factor release.

Area of Science:

  • Cardiovascular Physiology
  • Endothelial Function
  • Organ Preservation

Background:

  • Previous studies suggest high potassium (K+) in cardioplegic solutions may harm the coronary endothelium.
  • Direct functional changes in endothelium due to hyperkalemia remain understudied.

Purpose of the Study:

  • To investigate the effect of varying K+ concentrations in physiologic and cardioplegic solutions on porcine coronary artery endothelium and smooth muscle.
  • To assess the impact of exposure duration on these functional changes.

Main Methods:

  • Porcine coronary artery rings were exposed to Krebs' or St. Thomas' solutions with different K+ concentrations (5.9-50 mmol/L) for 2 or 4 hours.
  • Endothelial function was assessed by measuring endothelium-derived relaxing factor (EDRF) release in response to substance P.
  • Smooth muscle function was evaluated via K+-induced contraction and glyceryl trinitrate-induced relaxation.

Main Results:

  • High K+ concentrations (up to 50 mmol/L) in both solutions did not significantly decrease the maximal relaxation induced by substance P, indicating preserved endothelial function.
  • No significant impairment of smooth muscle function was observed based on contraction or relaxation responses.

Conclusions:

  • Hyperkalemia, at concentrations found in cardioplegic solutions, does not appear to directly impair endothelial or smooth muscle function in porcine coronary arteries under non-ischemic conditions.
  • Findings suggest that the coronary endothelium may be more resilient to hyperkalemia than previously inferred from coronary flow rate changes.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...